XML 47 R36.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Net Loss per Share (Tables)
 6 Months Ended
Jun. 30, 2024
Earnings Per Share [Abstract]  
Schedule of Antidilutive Shares Excluded From Calculation of Diluted Net Loss Per Share
The following table presents the potentially dilutive shares that were excluded from the computation of diluted net loss per share of Common Stock attributable to Common Stock stockholders because their effect was anti-dilutive:
Three Months Ended
June 30,		Six Months Ended
June 30,
2024202320242023
Shares issuable upon conversion of SPA Notes and settlement of make-whole provisions172,138,338 1,299,801 172,138,338 1,299,801 
Shares issuable upon conversion of Unsecured Convertible Notes35,910,221 — 35,910,221 — 
Shares issuable upon exercise of SPA Warrants568,738 389,881 568,738 389,881 
Other warrants 9,139,280 122,728 9,139,280 122,728 
Stock-based compensation awards – Options 98,588 154,925 98,588 154,925 
Stock-based compensation awards – RSUs 553,679 83,880 553,679 83,880 
Public warrants
98,088 98,088 98,088 98,088 
Private warrants464 464 464 464 
Total218,507,396 2,149,767 218,507,396 2,149,767